BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
6/4/2021 1:47:10 PM | Browse: 641 | Download: 844
 |
Received |
|
2021-02-13 03:52 |
|
Peer-Review Started |
|
2021-02-13 03:57 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2021-03-16 06:25 |
|
Revised |
|
2021-03-20 03:38 |
|
Second Decision |
|
2021-05-21 07:33 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Company Editor-in-Chief |
|
2021-05-21 12:15 |
|
Articles in Press |
|
2021-05-21 12:15 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2021-06-03 01:38 |
|
Publish the Manuscript Online |
|
2021-06-04 13:47 |
| ISSN |
1948-9358 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Endocrinology & Metabolism |
| Manuscript Type |
Review |
| Article Title |
Alzheimer’s disease and type 2 diabetes mellitus: Pathophysiologic and pharmacotherapeutics links
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Milagros Rojas, Mervin Chávez-Castillo, Jordan Bautista, Ángel Ortega, Manuel Nava, Juan Salazar, Edgar Díaz-Camargo, Oscar Medina, Joselyn Rojas-Quintero and Valmore Bermúdez |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Juan Salazar, MD, Doctor, Endocrine and Metabolic Diseases Research Center, School of Medicine, University of Zulia, 20th Avenue, Maracaibo 4004, Venezuela. juanjsv18@hotmail.com |
| Key Words |
Alzheimer’s disease; Type 2 diabetes mellitus; Oxidative stress; Islet amyloid polypeptide; Glucagon-like peptide 1; Cognitive dysfunction; Hypoglycemic agents |
| Core Tip |
Alzheimer’s disease and type 2 diabetes mellitus are highly prevalent chronic diseases that have shown a significant association. Important pathways have shown to be involved in this relationship, including the phosphatidylinositol 3-kinase and mitogen-activated protein kinase pathways, among others. This has led to the development of therapeutic approaches that can overlap and address both diseases. Some of the most promising interventions include the use of azeliragon, amylin, and glucagon-like peptide-1. |
| Publish Date |
2021-06-04 13:47 |
| Citation |
Rojas M, Chávez-Castillo M, Bautista J, Ortega Á, Nava M, Salazar J, Díaz-Camargo E, Medina O, Rojas-Quintero J, Bermúdez V. Alzheimer’s disease and type 2 diabetes mellitus: Pathophysiologic and pharmacotherapeutics links. World J Diabetes 2021; 12(6): 745-766 |
| URL |
https://www.wjgnet.com/1948-9358/full/v12/i6/745.htm |
| DOI |
https://dx.doi.org/10.4239/wjd.v12.i6.745 |
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
